Screening Program for Kidney Health in Type 2 Diabetes

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

Recruiting N/A Interventional Study
Chronic Kidney Disease(CKD) Type 2 DM Type 2 Diabetes Mellitus (T2DM)
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
500 (estimated)
Sponsor
Duke University · Other
Who this trial is looking for

This trial is looking for adults with type 2 diabetes to improve kidney screening. Participants will need to have had a visit with their primary doctor in the last two years and haven't had certain kidney tests in the past 15 months.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am an adult with type 2 diabetes
  • I have seen a primary care provider in the last 24 months
  • I have not had my kidney function tested in the last 15 months

You may not be able to join if

  • I have been diagnosed with chronic kidney disease

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

IRIS-CKD is an implementation study to improve guideline-recommended screening of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D) in the United States.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Screening Program- Inclusion Criteria: * Adults with type 2 diabetes (T2D) * Receiving primary care within the healthcare system, Primary Care Provider (PCP) visit within the past 24 months (any PCP provider, including APP). * Lack of estimated glomerular filtration rate (eGFR) and/or urine albumi…
Contacts

Gretchen Sanders, MSN

919 6687829

gretchen.sanders@duke.edu

CONTACT

Lisa Monk, MSN

lisa.monk@duke.edu

CONTACT